Mitsubishi UFJ Asset Management
CLPT icon

Mitsubishi UFJ Asset Management’s ClearPoint Neuro CLPT Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
+14,655
New +$183K ﹤0.01% 989

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CCM
Conway Capital Management Burbank, California $225M AUM 19.09% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mitsubishi UFJ Asset Management's CLPT Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 14,655 shares worth $261K. The stake represents ﹤0.01% of the portfolio and ranks #989 among its holdings.

45 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 14,655 shares of ClearPoint Neuro worth $261K as of Q2 2026.
  • ClearPoint Neuro was a new Mitsubishi UFJ Asset Management position in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #989 holding.
  • 45 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.